- HGENQ Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Humanigen (HGENQ) CORRESPCorrespondence with SEC
Filed: 11 Sep 20, 12:00am
HUMANIGEN, INC.
533 Airport Boulevard, Suite 400
Burlingame, California 94010
September 11, 2020
BY EDGAR
Mr. Tim Buchmiller
Mr. Joseph McCann
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Humanigen, Inc. Registration Statement on Form S-3 File No. 333-248485 |
Ladies and Gentlemen:
The undersigned registrant hereby requests that the effectiveness of the above-captioned Registration Statement on Form S-3 be accelerated so that the same will become effective at 4:05 p.m. Eastern Time on Monday, September 14, 2020, or as soon thereafter as practicable.
Very truly yours,
HUMANIGEN, INC.
By: | /s/ Cameron Durrant | |
Name: | Cameron Durrant, M.D., MBA | |
Title: | Chairman of the Board and Chief Executive Officer |
cc: | Kevin L. Vold |